High-Tech Gruenderfonds Invests in Startup Computomics

The non-GMO plant breeding industry increasingly uses high-throughput DNA sequencing to arrive at new crop varieties faster and more efficiently. Computomics offers the bioinformatics analysis services required to efficiently use high-throughput sequencing data. Services include genome assembly and annotation, genomic variation, transcriptomics, epigenetics, metagenomics, genomic selection, and phenotyping.

Sebastian J. Schultheiss, managing director at Computomics, describes the origin of the company name: “We apply computational methods to a plethora of –omics data, like genomics and transcriptomics, so we came up with the name Comput-omics.”

In addition to proven expertise and the delivery of reliable results, Computomics’ services feature independence from sequencing platforms and vendors, transparent processes and scientific reproducibility of all analyses. Computomics caters to an international market and already enables three of the top 10 seed manufacturing companies to obtain their new products faster and more efficiently. With the investment, the company will foster its international expansion.

“We are happy to join the company and the enthusiastic team. Sebastian and Tobias and their co-founders are internationally well-known experts in their field. With a strong customer base, we believe that Computomics has the potential to become a global player in ag biotech,” explains Ron Winkler, senior investment manager at High-Tech Gruenderfonds (HTGF).

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.